Macrogenics (MGNX) Stock Price, Quote & News

Company Profile

MacroGenics, Inc., a clinical-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes antibody-based therapeutics to treat cancer in the United States. The company's product pipeline includes lorigerlimab, a bispecific DART molecule that targets checkpoint inhibitors PD-1 and CTLA-4 for the treatment of mCRPC and docetaxel that is in phase 2 clinical trials, as well as for the treatment of platinum-resistant ovarian cancer and clear cell gynecologic cancer which ha...

Industry: Biotechnology

Sector: Healthcare

Phone: 301 251 5172

Fax: 301 251 5321

Website: www.macrogenics.com

Address:

9704 Medical Center Drive, Rockville, United States

Arcides Sep. 11 at 6:44 PM

$MGNX absolutely garbage...-27% from last friday high.

1 · Reply

Budman10 Sep. 11 at 5:08 PM

$MGNX For the love of god spend $20 million and buy back 20% of the company. Way below market value. Announce a share buy back.

1 · Reply

PSDL75 Sep. 11 at 3:39 PM

$MGNX make it make sense

0 · Reply

PSDL75 Sep. 11 at 3:33 PM

$MGNX

0 · Reply

D3Squire Sep. 10 at 2:29 PM

$MGNX selling pressure done…now we run to 1.79

1 · Reply

MarketWarfare Sep. 9 at 2:43 PM

$MGNX wtf is wrong with this stock?

1 · Reply

Arcides Sep. 8 at 7:51 PM

$MGNX pupu in 2 days...

1 · Reply

Budman10 Sep. 8 at 4:16 PM

$MGNX there were a lot of promising results from the call. We’re just going to need to be patient a little bit longer.

1 · Reply

PSDL75 Sep. 8 at 3:50 PM

$MGNX conference going and not helping some relief.. so depressed

1 · Reply

Therule0flaw Sep. 8 at 3:30 PM

$MGNX 💩

1 · Reply

MacroGenics to Present at H.C. Wainwright 27th Annual Global Investment Conference

Aug 14, 2025, 4:01 PM EDT - 4 weeks ago

MacroGenics Reports Second Quarter 2025 Financial Results and Highlights Key Strategic Priorities

Aug 13, 2025, 4:01 PM EDT - 4 weeks ago

MacroGenics Appoints Eric Risser as President and Chief Executive Officer

Jun 11, 2025, 6:32 PM EDT - 3 months ago

MacroGenics: Working On That Road To Recovery

Jun 10, 2025, 7:00 AM EDT - 3 months ago

MacroGenics and Sagard Healthcare Partners Enter into ZYNYZ® Royalty Purchase Agreement

Jun 3, 2025, 4:30 PM EDT - 3 months ago

MacroGenics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025

May 13, 2025, 4:01 PM EDT - 4 months ago

MacroGenics Provides Update on Corporate Progress and First Quarter 2025 Financial Results

May 6, 2025, 4:30 PM EDT - 4 months ago

MacroGenics Announces Date of First Quarter 2025 Financial Results

May 1, 2025, 4:30 PM EDT - 4 months ago

MacroGenics to Participate in Upcoming Investor Conference

Mar 20, 2025, 7:09 PM EDT - 6 months ago

MacroGenics, Inc. (MGNX) Q4 2024 Earnings Call Transcript

Mar 6, 2025, 7:30 AM EST - 6 months ago

MacroGenics Announces Date of Fourth Quarter and Full Year 2024 Financial Results Conference Call

Feb 27, 2025, 2:08 PM EST - 7 months ago

MacroGenics: Stacking Up A Lot Of Headwinds

Feb 27, 2025, 7:30 AM EST - 7 months ago

MacroGenics to Participate in Upcoming Investor Conferences

Nov 5, 2024, 7:01 PM EST - 11 months ago

MacroGenics, Inc. (MGNX) Q2 2024 Earnings Call Transcript

Nov 5, 2024, 4:01 PM EST - 11 months ago

MacroGenics Provides Update on Corporate Progress, Third Quarter 2024 Financial Results

Oct 30, 2024, 7:30 AM EDT - 11 months ago

MacroGenics Announces Leadership Transition

Oct 29, 2024, 4:30 PM EDT - 11 months ago

MacroGenics Announces Date of Third Quarter 2024 Financial Results Conference Call

Oct 25, 2024, 5:15 PM EDT - 11 months ago

Rigrodsky Law, P.A. Is Investigating MacroGenics, Inc. On Behalf of Shareholders

Oct 22, 2024, 7:30 AM EDT - 11 months ago

MacroGenics Enters Into Agreement With TerSera Therapeutics for the Sale of MARGENZA®

Sep 24, 2024, 12:57 PM EDT - 1 year ago

Shareholders of MacroGenics, Inc. Should Contact The Gross Law Firm Before September 24, 2024 to Discuss Your Rights – MGNX

Sep 24, 2024, 10:30 AM EDT - 1 year ago

MGNX Investors Have Opportunity to Join MacroGenics, Inc. Fraud Investigation with the Schall Law Firm

Sep 23, 2024, 11:00 AM EDT - 1 year ago

MacroGenics Inc Is Being Sued For Violating Securities Laws And Shareholders With Losses Are Encouraged To Contact The Schall Law Firm

Sep 22, 2024, 11:09 AM EDT - 1 year ago

MacroGenics (MGNX) Accused of Misleading Investors Over Cancer Drug Trial - Hagens Berman

Sep 21, 2024, 11:00 AM EDT - 1 year ago

MacroGenics Inc Is Being Sued For Violating Securities Laws And Shareholders With Losses Are Urged To Reach Out To The Schall Law Firm

Sep 19, 2024, 11:00 AM EDT - 1 year ago

MacroGenics Inc Is Being Sued For Violating Securities Laws And Shareholders Are Urged To Contact The Schall Law Firm

Sep 19, 2024, 9:57 AM EDT - 1 year ago

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MacroGenics

Sep 19, 2024, 5:45 AM EDT - 1 year ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of September 24, 2024 in MacroGenics Lawsuit - MGNX

Sep 17, 2024, 11:23 AM EDT - 1 year ago

MGNX Deadline: Rosen Law Firm Urges MacroGenics, Inc. (NASDAQ: MGNX) Stockholders with Large Losses in Excess of $100K to Contact the Firm for Information About Their Rights

Sep 17, 2024, 11:04 AM EDT - 1 year ago

Hospice Dynamix Welcomes Industry Veteran Rob Stoltz as Chief Strategy Officer

Sep 17, 2024, 11:00 AM EDT - 1 year ago

MacroGenics Inc May Have Violated Securities Laws And Shareholders With Losses Are Urged To Contact The Schall Law Firm About A Suit

Sep 16, 2024, 12:14 PM EDT - 1 year ago

Investor Reminder (MGNX): Kessler Topaz Meltzer & Check, LLP Reminds MacroGenics, Inc. Investors of September 24, 2024 Deadline

Sep 15, 2024, 11:00 AM EDT - 1 year ago

MacroGenics Inc Is Being Sued For Violating Securities Laws And Impacted Shareholders Are Urged To Contact The Schall Law Firm

Sep 15, 2024, 3:00 AM EDT - 1 year ago

MacroGenics Announces Updated Efficacy & Safety Data from TAMARACK Phase 2 Study of Vobra Duo in mCRPC Patients at ESMO Congress 2024

Arcides Sep. 11 at 6:44 PM

$MGNX absolutely garbage...-27% from last friday high.

1 · Reply

Budman10 Sep. 11 at 5:08 PM

$MGNX For the love of god spend $20 million and buy back 20% of the company. Way below market value. Announce a share buy back.

1 · Reply

PSDL75 Sep. 11 at 3:39 PM

$MGNX make it make sense

0 · Reply

PSDL75 Sep. 11 at 3:33 PM

$MGNX

0 · Reply

D3Squire Sep. 10 at 2:29 PM

$MGNX selling pressure done…now we run to 1.79

1 · Reply

MarketWarfare Sep. 9 at 2:43 PM

$MGNX wtf is wrong with this stock?

1 · Reply

Arcides Sep. 8 at 7:51 PM

$MGNX pupu in 2 days...

1 · Reply

Budman10 Sep. 8 at 4:16 PM

$MGNX there were a lot of promising results from the call. We’re just going to need to be patient a little bit longer.

1 · Reply

PSDL75 Sep. 8 at 3:50 PM

$MGNX conference going and not helping some relief.. so depressed

1 · Reply

Therule0flaw Sep. 8 at 3:30 PM

$MGNX 💩

1 · Reply

MarketWarfare Sep. 8 at 3:25 PM

$MGNX terrible

0 · Reply

PSDL75 Sep. 8 at 2:47 PM

$PBYI $MGNX price action on Bios suggests sell the potential news with all these conferences?

0 · Reply

Budman10 Sep. 8 at 2:37 PM

$MGNX I think they were speculation that news would drop before the conference.

1 · Reply

PSDL75 Sep. 8 at 1:24 PM

$MGNX Here's where I think this move can go in the short run...see if the conference can get us some juice

0 · Reply

PMD777 Sep. 8 at 12:36 PM

$MGNX wondering if the pattern continues- higher highs pretty far off

0 · Reply

Budman10 Sep. 6 at 1:51 PM

$MGNX What do you guys make of this action last week or so? The stock runs with all the buys during the day and then they purposely bring it down at the end of the day. Volume has been picking up significantly, short position is shrinking, and there’s a lot of anticipation of news coming. For me it singles something big may be coming.

2 · Reply

PSDL75 Sep. 5 at 6:23 PM

$MGNX criminal

0 · Reply

PSDL75 Sep. 5 at 6:14 PM

$MGNX price action here is just atrocious.. took it down to $2.05 on nothing and then 50k purchase hardly moves it....

0 · Reply